Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Allergan,_Inc.
gptkb:Warner_Chilcott |
| gptkbp:country |
gptkb:Ireland
|
| gptkbp:dissolved |
2015
|
| gptkbp:formerName |
Watson Pharmaceuticals, Inc.
|
| gptkbp:founded |
1984
|
| gptkbp:founder |
gptkb:Allen_Chao
|
| gptkbp:headquarters_location |
gptkb:Dublin,_Ireland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Actavis plc
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Paul_Bisaro
|
| gptkbp:mergedInto |
gptkb:Allergan,_Inc.
|
| gptkbp:numberOfEmployees |
~21,600 (2014)
|
| gptkbp:products |
biosimilars
generic drugs branded pharmaceuticals |
| gptkbp:stockExchange |
gptkb:New_York_Stock_Exchange
|
| gptkbp:successor |
gptkb:Allergan_plc
|
| gptkbp:tradedOn |
gptkb:NYSE:_ACT
|
| gptkbp:website |
www.actavis.com
|
| gptkbp:bfsParent |
gptkb:Allergan,_Inc.
gptkb:NYSE:_ACT |
| gptkbp:bfsLayer |
7
|